Goldman Sachs Group Inc Fibrogen Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Fibrogen Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 51,567 shares of FGEN stock, worth $17,532. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,567
Previous 1,091,512 95.28%
Holding current value
$17,532
Previous $971,000 97.94%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.33 - $1.26 $343,181 - $1.31 Million
-1,039,945 Reduced 95.28%
51,567 $20,000
Q2 2024

Aug 13, 2024
BUY
$0.89 - $2.36 $881,405 - $2.34 Million
990,343 Added 978.9%
1,091,512 $971,000
Q1 2024

May 15, 2024
SELL
$0.73 - $2.73 $91,536 - $342,322
-125,393 Reduced 55.35%
101,169 $237,000
Q4 2023

Feb 13, 2024
SELL
$0.38 - $0.91 $68,676 - $164,461
-180,727 Reduced 44.37%
226,562 $201,000
Q3 2023

May 14, 2024
BUY
$0.79 - $2.83 $142,774 - $511,457
180,727 Added 79.77%
407,289 $350,000
Q3 2023

Nov 14, 2023
SELL
$0.79 - $2.83 $380,362 - $1.36 Million
-481,472 Reduced 54.17%
407,289 $350,000
Q2 2023

May 14, 2024
BUY
$2.49 - $20.59 $824,292 - $6.82 Million
331,041 Added 59.36%
888,761 $2.4 Million
Q2 2023

Aug 14, 2023
BUY
$2.49 - $20.59 $824,292 - $6.82 Million
331,041 Added 59.36%
888,761 $2.4 Million
Q1 2023

May 14, 2024
BUY
$15.95 - $25.18 $1.83 Million - $2.88 Million
114,435 Added 25.82%
557,720 $10.4 Million
Q1 2023

May 11, 2023
BUY
$15.95 - $25.18 $1.83 Million - $2.88 Million
114,435 Added 25.82%
557,720 $10.4 Million
Q4 2022

May 14, 2024
SELL
$13.27 - $17.73 $2.45 Million - $3.27 Million
-184,254 Reduced 29.36%
443,285 $7.1 Million
Q4 2022

Feb 13, 2023
SELL
$13.27 - $17.73 $2.45 Million - $3.27 Million
-184,254 Reduced 29.36%
443,285 $7.1 Million
Q3 2022

May 14, 2024
SELL
$11.4 - $14.6 $1.24 Million - $1.59 Million
-109,011 Reduced 14.8%
627,539 $8.16 Million
Q3 2022

Nov 10, 2022
SELL
$11.4 - $14.6 $1.24 Million - $1.59 Million
-109,011 Reduced 14.8%
627,539 $8.16 Million
Q2 2022

May 14, 2024
BUY
$7.94 - $12.96 $4.05 Million - $6.61 Million
509,988 Added 225.1%
736,550 $7.78 Million
Q2 2022

Aug 15, 2022
BUY
$7.94 - $12.96 $480,227 - $783,846
60,482 Added 8.95%
736,550 $7.78 Million
Q1 2022

May 16, 2022
SELL
$12.02 - $16.79 $4.01 Million - $5.6 Million
-333,608 Reduced 33.04%
676,068 $8.13 Million
Q4 2021

Feb 14, 2022
BUY
$9.93 - $15.39 $1.06 Million - $1.64 Million
106,654 Added 11.81%
1,009,676 $14.2 Million
Q3 2021

Nov 10, 2021
BUY
$10.18 - $26.64 $9.19 Million - $24.1 Million
903,022 New
903,022 $9.23 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email